
Trump Threatens 100% Tariffs on Patented Drugs Unless Firms Build U.S. Plants
Published September 26, 2025
Share this card
A satirical card depicting the dramatic ultimatum: 100% tariffs on branded drug imports unless pharmaceutical firms break ground on U.S. factories, showing collapsing foreign drugmakers and frantic domestic build efforts.
Trump announced that starting October 1, the U.S. will impose a 100% tariff on imported branded or patented pharmaceutical products, unless the companies are actively building manufacturing plants in the U.S. The exemption applies only to firms that are already “breaking ground” or “under construction.” Generic drugs aren’t included in the measure. The move is intended to force onshoring of drug production and reduce reliance on foreign pharmaceutical imports.
Read the original article →Congressman Declares Alien Contact, Claims Secrets Will 'Keep You Up at Night'
Apr 25, 2026
Kash Patel Arrested for Public Urination After Night Out
Apr 25, 2026
Meta Announces 10% Workforce Reduction as AI Efforts Ramp Up
Apr 25, 2026
Google Cloud Customer Faces $18,000 Bill Due to Exposed API Key
Apr 24, 2026